Suppr超能文献

在尿激酶受体表达时,玻连蛋白和尿激酶在调节细胞形态方面的复合作用。

A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.

作者信息

Hillig Thore, Engelholm Lars H, Ingvarsen Signe, Madsen Daniel H, Gårdsvoll Henrik, Larsen Jørgen K, Ploug Michael, Danø Keld, Kjøller Lars, Behrendt Niels

机构信息

The Finsen Laboratory, Department 37.35, Rigshospitalet, Ole Maaløes Vej 5, Copenhagen North, Denmark.

出版信息

J Biol Chem. 2008 May 30;283(22):15217-23. doi: 10.1074/jbc.C700214200. Epub 2008 Mar 24.

Abstract

The urokinase receptor, urokinase receptor (uPAR), is a glycosylphosphatidylinositol-anchored membrane protein engaged in pericellular proteolysis and cellular adhesion, migration, and modulation of cell morphology. A direct matrix adhesion is mediated through the binding of uPAR to vitronectin, and this event is followed by downstream effects including changes in the cytoskeletal organization. However, it remains unclear whether the adhesion through uPAR-vitronectin is the only event capable of initiating these morphological rearrangements or whether lateral interactions between uPAR and integrins can induce the same response. In this report, we show that both of these triggering mechanisms can be operative and that uPAR-dependent modulation of cell morphology can indeed occur independently of a direct vitronectin binding. Expression of wild-type uPAR on HEK293 cells led to pronounced vitronectin adhesion and cytoskeletal rearrangements, whereas a mutant uPAR, uPAR(W32A) with defective vitronectin binding, failed to induce both phenomena. However, upon saturation of uPAR(W32A) with the protease ligand, pro-uPA, or its receptor-binding domain, the ability to induce cytoskeletal rearrangements was restored, although this did not rescue the uPAR-vitronectin binding and adhesion capability. On the other hand, using other uPAR variants, we could show that uPAR-vitronectin adhesion is indeed capable and sufficient to induce the same morphological rearrangements. This was shown with cells expressing a different single-site mutant, uPAR(Y57A), in the presence of a synthetic uPAR-binding peptide, as well as with wild-type uPAR, which underwent cytoskeletal rearrangements even when cultivated in uPA-deficient serum. Blocking of integrins with an Arg-Gly-Asp-containing peptide counteracted the matrix contacts necessary to initiate the uPAR-dependent cytoskeletal rearrangements, whereas inactivation of the Rac signaling pathway in all cases suppressed the occurrence of the same events.

摘要

尿激酶受体(urokinase receptor,uPAR)是一种糖基磷脂酰肌醇锚定膜蛋白,参与细胞周围蛋白水解以及细胞黏附、迁移和细胞形态调节。uPAR与玻连蛋白结合介导直接的基质黏附,此事件之后会产生包括细胞骨架组织变化在内的下游效应。然而,通过uPAR-玻连蛋白的黏附是否是唯一能够引发这些形态重排的事件,或者uPAR与整合素之间的侧向相互作用是否能诱导相同反应,仍不清楚。在本报告中,我们表明这两种触发机制均可起作用,且uPAR依赖的细胞形态调节确实可独立于直接的玻连蛋白结合而发生。野生型uPAR在HEK293细胞上的表达导致明显的玻连蛋白黏附和细胞骨架重排,而具有缺陷的玻连蛋白结合能力的突变型uPAR,即uPAR(W32A),未能诱导这两种现象。然而,用蛋白酶配体、pro-uPA或其受体结合结构域使uPAR(W32A)饱和后,诱导细胞骨架重排的能力得以恢复,尽管这并未挽救uPAR-玻连蛋白的结合及黏附能力。另一方面,使用其他uPAR变体,我们可以表明uPAR-玻连蛋白黏附确实能够且足以诱导相同的形态重排。在存在合成uPAR结合肽的情况下,表达不同单点突变体uPAR(Y57A)的细胞以及野生型uPAR均显示了这一点,野生型uPAR即使在缺乏uPA的血清中培养时也会发生细胞骨架重排。用含精氨酸-甘氨酸-天冬氨酸的肽阻断整合素可抵消启动uPAR依赖的细胞骨架重排所需的基质接触,而在所有情况下Rac信号通路的失活均抑制了相同事件的发生。

相似文献

引用本文的文献

3
uPAR: An Essential Factor for Tumor Development.尿激酶型纤溶酶原激活物受体:肿瘤发展的关键因素
J Cancer. 2021 Oct 17;12(23):7026-7040. doi: 10.7150/jca.62281. eCollection 2021.

本文引用的文献

2
Does the urokinase receptor exist in a latent form?尿激酶受体是否以潜伏形式存在?
Cell Mol Life Sci. 2007 May;64(9):1033-7. doi: 10.1007/s00018-007-6498-z.
10
Plasminogen activation and cancer.纤溶酶原激活与癌症
Thromb Haemost. 2005 Apr;93(4):676-81. doi: 10.1160/TH05-01-0054.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验